Christopher David Taves - Net Worth and Insider Trading
Christopher David Taves Net Worth
The estimated net worth of Christopher David Taves is at least $70,000 dollars as of 2024-09-23. Christopher David Taves is the Director of MediPharm Labs Corp and owns about 1,000,000 shares of MediPharm Labs Corp (TSX:LABS) stock worth over $70,000. Details can be seen in Christopher David Taves's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher David Taves has not made any transactions after 2021-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher David Taves
Christopher David Taves Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher David Taves owns 1 companies in total, including MediPharm Labs Corp (TSX:LABS) .
Click here to see the complete history of Christopher David Taves’s form 4 insider trades.
Insider Ownership Summary of Christopher David Taves
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:LABS | MediPharm Labs Corp | 2021-05-27 | Director |
Christopher David Taves Latest Holdings Summary
Christopher David Taves currently owns a total of 1 stock. Christopher David Taves owns 1,000,000 shares of MediPharm Labs Corp (TSX:LABS) as of May 27, 2021, with a value of $70,000.
Latest Holdings of Christopher David Taves
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:LABS | MediPharm Labs Corp | 2021-05-27 | 1,000,000 | 0.07 | 70,000 |
Holding Weightings of Christopher David Taves
Christopher David Taves Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher David Taves has made a total of 5 transactions in MediPharm Labs Corp (TSX:LABS) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in MediPharm Labs Corp is the acquisition of 200,000 shares on May 27, 2021, which cost Christopher David Taves around $105,920.
Insider Trading History of Christopher David Taves
- 1
Christopher David Taves Trading Performance
GuruFocus tracks the stock performance after each of Christopher David Taves's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher David Taves is -28.88%. GuruFocus also compares Christopher David Taves's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher David Taves within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher David Taves's insider trading performs compared to the benchmark.
Performance of Christopher David Taves
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.25 | | | | | |
| Relative Return to S&P 500(%) | -0.15 | | | | | |
Christopher David Taves Ownership Network
Christopher David Taves Owned Company Details
What does MediPharm Labs Corp do?
Who are the key executives at MediPharm Labs Corp?
Christopher David Taves is the Director of MediPharm Labs Corp. Other key executives at MediPharm Labs Corp include Senior Officer Gregory Edison Hunter , Director & Senior Officer David Pidduck , and Director & Senior Officer Bryan Howcroft .
MediPharm Labs Corp (TSX:LABS) Insider Trades Summary
Over the past 18 months, Christopher David Taves made no insider transaction in MediPharm Labs Corp (TSX:LABS). Other recent insider transactions involving MediPharm Labs Corp (TSX:LABS) include a net sale of 399,773 shares made by Keith Strachan , a net sale of 2,031,162 shares made by David Pidduck , and a net sale of 211,257 shares made by Gregory Edison Hunter .
In summary, during the past 3 months, insiders sold 0 shares of MediPharm Labs Corp (TSX:LABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,642,192 shares of MediPharm Labs Corp (TSX:LABS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,642,192 shares.
MediPharm Labs Corp (TSX:LABS)'s detailed insider trading history can be found in Insider Trading Tracker table.
MediPharm Labs Corp Insider Transactions
Christopher David Taves Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher David Taves. Currently GuruFocus does not have mailing address information for Christopher David Taves.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
